Trade Names: | |
Synonyms: | |
Status: | Approved (1953) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | P01BD01 |
UNII: | Z3614QOX8W |
InChI Key | WKSAUQYGYAYLPV-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C12H13ClN4 |
Molecular Weight | 248.72 |
AlogP | 2.52 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 77.82 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 17.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | - | - | 51500 | - | |
Enzyme
Hydrolase
|
- | 3100-17000 | - | - | - | |
Enzyme
Oxidoreductase
|
- | 80-390 | 1-16 | 0-860 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 107 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 13570 | - | 3600 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | - | - | 145 | - | |
Unclassified protein
|
- | 2480 | - | 1 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Toxoplasmosis | 4 | D014123 | ClinicalTrials |
Depressive Disorder | 3 | D003866 | ClinicalTrials |
Pregnancy | 3 | D011247 | ClinicalTrials |
HIV Infections | 3 | D015658 | ClinicalTrials |
HIV Infections | 3 | D015658 | ClinicalTrials |
Pneumonia, Pneumocystis | 3 | D011020 | ClinicalTrials |
Chorioretinitis | 3 | D002825 | ClinicalTrials |
Schizophrenia | 3 | D012559 | ClinicalTrials |
Premature Birth | 3 | D047928 | ClinicalTrials |
Anemia | 3 | D000740 | ClinicalTrials |
Toxoplasmosis, Congenital | 3 | D014125 | ClinicalTrials |
Malaria, Falciparum | 3 | D016778 | ClinicalTrials |
Malaria, Vivax | 3 | D016780 | ClinicalTrials |
Schistosomiasis | 3 | D012552 | ClinicalTrials |
Toxoplasmosis, Cerebral | 2 | D016781 | ClinicalTrials |
Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Amyotrophic Lateral Sclerosis | 1 | D000690 | ClinicalTrials |
Sandhoff Disease | 1 | D012497 | ClinicalTrials |
Tay-Sachs Disease | 1 | D013661 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 58-14-0 |
ChEBI | 8673 |
ChEMBL | CHEMBL36 |
DrugBank | DB00205 |
DrugCentral | 2332 |
EPA CompTox | DTXSID9021217 |
FDA SRS | Z3614QOX8W |
Human Metabolome Database | HMDB0014350 |
Guide to Pharmacology | 4800 |
KEGG | C07391 |
PDB | CP6 |
PharmGKB | PA451193 |
PubChem | 4993 |
SureChEMBL | SCHEMBL25129 |
ZINC | ZINC000000057464 |